Assessing Potential Benefit of Stroke Prophylaxis Therapy in Atrial Fibrillation and Atrial Flutter Using a Novel Competing Risk Scoring Tool
Open Access
- 17 February 2026
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (4) , e044151
Abstract
Background: The competing risk of nonstroke mortality may limit the potential benefit of stroke prophylaxis therapy in patients with atrial fibrillation or atrial flutter AF. Methods: Using a Medicare 20% sample, we identified a cohort of beneficiaries diagnosed with atrial fibrillation or atrial flutter from 2006 to 2019 using International Classification of Diseases, Ninth Revision ( ICD‐9 ) and Tenth Revision ( ICD‐10 ) codes. Fine and Gray regression analysis determined the hazard of stroke with a competing risk of nonstroke mortality, and Cox proportional hazard analysis determined risk of nonstroke mortality. A scoring tool stratified patients into low or high potential benefit for thromboembolic prophylaxis. Results: Among a total of 1 883 759 Medicare beneficiaries, 330 136 patients were included with median age of 79.7 years. 54% of patients had prior bleeding episodes. The median CHA 2 DS 2 ‐VASc score was 5. Of these patients, 211 791 (64%) died and 77 717 (24%) experienced an embolic stroke over median follow‐up of 7.3 years. In the high potential benefit group (26.1%), the risk of stroke was much higher than the risk of nonstroke mortality at 1 year (12.2% versus 7.1%); 3 years (22.7% versus 16.9%); 5 years (31.9% versus 26.1%). In the low potential benefit group (73.9%), the risk of stroke was much lower than the risk of nonstroke mortality at 1 year (11.5% versus 39.2%); 3 years (23.2 versus 57.2%); and 5 years (34.3% versus 69.4%). Conclusions: We propose a scoring tool to identify the potential benefit of thromboembolic prophylaxis therapy in older patients diagnosed with atrial fibrillation or atrial flutter. This tool can be used in shared decision‐making settings. Further studies to improve and validate this scoring tool are warranted.Keywords
This publication has 30 references indexed in Scilit:
- Competing Risks in Clinical TrialsJACC, 2024
- Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF RegistryThe American Journal of Medicine, 2023
- Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an AnticoagulantJAMA Network Open, 2023
- Ischemic Stroke Risk in Patients With Nonvalvular Atrial FibrillationJACC, 2019
- Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillationAmerican Heart Journal, 2019
- The Effect of Bleeding Risk and Frailty Status on Anticoagulation Patterns in Octogenarians With Atrial Fibrillation: The FRAIL-AF StudyCanadian Journal of Cardiology, 2016
- Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic ReviewThe American Journal of Medicine, 2010
- Are Atrial Fibrillation Patients Receiving Warfarin in Accordance with Stroke Risk?The American Journal of Medicine, 2010
- Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate AnticoagulationJACC, 2005
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001